AR045117A1 - Imidazo-pirimidinas y triazolo-pirimidinas:ligandos del receptor de benzodiazepina - Google Patents
Imidazo-pirimidinas y triazolo-pirimidinas:ligandos del receptor de benzodiazepinaInfo
- Publication number
- AR045117A1 AR045117A1 ARP040102649A ARP040102649A AR045117A1 AR 045117 A1 AR045117 A1 AR 045117A1 AR P040102649 A ARP040102649 A AR P040102649A AR P040102649 A ARP040102649 A AR P040102649A AR 045117 A1 AR045117 A1 AR 045117A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- amino
- halogen
- cyano
- nitro
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compuesto y composición farmacéutica útiles para modular la unión de ligando a receptor GABAa, para trastornos del SNC, memoria o demencia de Alzheimer. Reivindicación 1: Un compuesto de formula (1) o una de sus sales aceptables desde el punto de vista farmacéutico, en la que: Z1 es N o CR1; Z2 es N o CR2, y Z3 es N o CR3, tal que por lo menos uno, aunque no más de dos, de Z1, Z2, y Z3 son N; R1, R2, R3 y R4 se seleccionan, cada uno de forma independiente, de: (a) H, halógeno, nitro y ciano; y (b) grupos de la fórmula (2) en la que: L es un enlace o alquileno C1-8; G es un enlace, N(RB), O, C(=O), C(=O)O, C(=O)N(RB), N(RB)C(=O), S(O)m, CH2C(=O), S(=O)mN(RB) o N(RB)S(O)m; en los que m es 0, 1 o 2; y RA y cada RB se seleccionan en forma independiente de: (i) H; y (ii) alquilo C1-8, alquenilo C2-8, alquinilo C2-8, (cicloalquil C3-8)alquilo C0-4, (heterocicloalquilo de 3 a 7 miembros)alquilo C0-4, (aril C6-10)alquilo C0-2 o (heteroarilo de 5 a 10 miembros)alquilo C0-2, cada uno de los cuales está sustituido con desde 0 hasta 4 sustituyentes seleccionados en forma independiente de halógeno, hidroxi, nitro, ciano, amino, alquilo C1-4, alcoxi C1-4, alcanoilo C1-4, mono- y di(alquil C1-4)amino, haloalquilo C1-4 y haloalcoxi c1-4; R5 es (a) H, halógeno o ciano; o (b) alquilo C1-6, alquenilo C2-6, alquinilo C2-6, alcoxi C1-4 o mono- o di(alquil C1-4)amino, cada uno de los cuales está sustituido con desde 0 hasta 5 sustituyentes elegidos en forma independiente de halógeno, hidroxi, nitro, ciano, amino, alcoxi C1-4, haloalquilo C1-2, haloalcoxi C1-2, mono- y di(alquil C1-4)amino, cicloalquilo C3-8, fenilo, fenilalcoxi c1-4 y heteroarilo de 5 o 6 miembros; R6 y R7 son, en forma independiente, H, metilo, etilo o halógeno; R8 representa 0, 1 o 2 sustituyentes elegidos en forma independiente de halógeno, hidroxi, nitro, ciano, amino, alquilo C1-4, alcoxi C1-4, mono- y di(alquil C1-4)amino, cicloalquilo C3-7, haloalquilo C1-2 y haloalcoxi C1-2; y Ar representa fenilo, naftilo o heteroarilo de 5 a 10 miembros, cada uno de los cuales está sustituido con desde 0 hasta 4 sustituyentes elegidos en forma independiente de halógeno, hidroxi, nitro, ciano, amino, alquilo C1-8, alquenilo C1-8, alquinilo C1-8, alcoxi C1-8, (cicloalquil C3-7)alquilo C0-4, (cicloalquil C3-7)alcoxi C1-4, alquilo C1-8, éter, alcanona c1-8, alcanoilo C1-8, (heterocicloalquilo de 3 a 7 miembros)alquilo C0-4, haloalquilo C1-8, haloalcoxi C1-8, oxo, hidroxialquilo C1-8, aminoalquilo C1-8, y mono- y di(alquil C1-8)amino alquilo C0-8.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US49000603P | 2003-07-25 | 2003-07-25 | |
US54308304P | 2004-02-09 | 2004-02-09 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR045117A1 true AR045117A1 (es) | 2005-10-19 |
Family
ID=34118813
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP040102649A AR045117A1 (es) | 2003-07-25 | 2004-07-26 | Imidazo-pirimidinas y triazolo-pirimidinas:ligandos del receptor de benzodiazepina |
Country Status (21)
Country | Link |
---|---|
US (2) | US7271170B2 (es) |
EP (1) | EP1648899B1 (es) |
JP (1) | JP2007500130A (es) |
KR (1) | KR20060098425A (es) |
AR (1) | AR045117A1 (es) |
AT (1) | ATE350382T1 (es) |
AU (1) | AU2004261591A1 (es) |
BR (1) | BRPI0412908A (es) |
CA (1) | CA2537331A1 (es) |
CY (1) | CY1107565T1 (es) |
DE (1) | DE602004004143T2 (es) |
DK (1) | DK1648899T3 (es) |
ES (1) | ES2278345T3 (es) |
HK (1) | HK1089446A1 (es) |
IL (1) | IL173265A0 (es) |
MX (1) | MXPA06000887A (es) |
NZ (1) | NZ544262A (es) |
PL (1) | PL1648899T3 (es) |
PT (1) | PT1648899E (es) |
TW (1) | TW200524937A (es) |
WO (1) | WO2005012306A2 (es) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7482366B2 (en) * | 2001-12-21 | 2009-01-27 | X-Ceptor Therapeutics, Inc. | Modulators of LXR |
JP2007501272A (ja) * | 2003-05-05 | 2007-01-25 | ニューロジェン・コーポレーション | 置換イミダゾロピラジンおよびトリアゾロピラジン誘導体類:gabaaレセプタリガンド類 |
WO2006093911A2 (en) * | 2005-03-02 | 2006-09-08 | Neurogen Corporation | Thiazolylmethyl and oxazolylmethyl heteroaryl derivatives |
EP1928237A4 (en) | 2005-09-02 | 2011-03-09 | Abbott Lab | NEW HETEROCYCLES BASED ON IMIDAZO |
JP2010523716A (ja) * | 2007-04-11 | 2010-07-15 | サイプレス バイオサイエンシズ,インク. | ベンゾジアゼピン受容体拮抗薬を用いるダウン症候群の治療 |
US8546394B2 (en) | 2007-04-17 | 2013-10-01 | Bristol-Myers Squibb Company | Substituted [1,2,4]triazolo[4,3-A]pyrazine 11-beta-hydroxysteroid dehydrogenase inhibitors |
GB0719803D0 (en) | 2007-10-10 | 2007-11-21 | Cancer Rec Tech Ltd | Therapeutic compounds and their use |
US20090270373A1 (en) * | 2008-04-11 | 2009-10-29 | Cypress Biosciences, Inc. | Treatment of down syndrom with benzodiazepine receptor antagonists |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US544057A (en) * | 1895-08-06 | Bill and letter file | ||
WO2000059905A1 (en) * | 1999-04-02 | 2000-10-12 | Neurogen Corporation | ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
US6737242B1 (en) | 1999-05-07 | 2004-05-18 | Neurogen Corporation | Methods for screening GABA-modulatory compounds for specified pharmacological activities |
GB9929687D0 (en) | 1999-12-15 | 2000-02-09 | Merck Sharp & Dohme | Therapeutic agents |
AU2001270297A1 (en) * | 2000-06-30 | 2002-01-14 | Neurogen Corporation | 2-phenylimidazo(1,2-a)pyridine derivatives: a new class of gaba brain receptor ligands |
GB0027561D0 (en) * | 2000-11-10 | 2000-12-27 | Merck Sharp & Dohme | Therapeutic agents |
US6900215B2 (en) * | 2000-12-15 | 2005-05-31 | Merck Sharp & Dohme Ltd. | Imidazo-pyrimidine derivatives as ligands for gaba receptors |
PA8535601A1 (es) | 2000-12-21 | 2002-11-28 | Pfizer | Derivados benzimidazol y piridilimidazol como ligandos para gabaa |
TWI248936B (en) * | 2001-03-21 | 2006-02-11 | Merck Sharp & Dohme | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
US7030128B2 (en) * | 2001-03-23 | 2006-04-18 | Merck Sharp & Dohme Ltd. | Imidazo-pyrimidine derivatives as ligands for GABA receptors |
IL159811A0 (en) | 2001-07-13 | 2004-06-20 | Neurogen Corp | Heteroaryl substituted fused bicyclic heteroaryl compounds as gabaa receptor ligands |
GB0128499D0 (en) * | 2001-11-28 | 2002-01-23 | Merck Sharp & Dohme | Therapeutic agents |
JP2005531548A (ja) | 2002-05-02 | 2005-10-20 | ニューロジェン コーポレイション | 置換イミダゾール誘導体:gabaa受容体リガンド |
US6982268B2 (en) | 2002-05-08 | 2006-01-03 | Neurogen Corporation | Substituted imidazolylmethyl pyridine and pyrazine derivatives GABAA receptor ligands |
ATE333455T1 (de) | 2002-05-17 | 2006-08-15 | Neurogen Corp | Substituierte, ringkondensierte imidazolderivate: gabaa-rezeptorliganden |
CN100579579C (zh) | 2002-10-01 | 2010-01-13 | 诺华疫苗和诊断公司 | 抗癌及抗感染性疾病组合物及其使用方法 |
ES2268488T3 (es) | 2002-11-08 | 2007-03-16 | Neurogen Corporation | Derivados de 4-imidazol-1-ilmetil-pirimidina como ligandos para receptores de gabaa. |
JP2007501272A (ja) | 2003-05-05 | 2007-01-25 | ニューロジェン・コーポレーション | 置換イミダゾロピラジンおよびトリアゾロピラジン誘導体類:gabaaレセプタリガンド類 |
-
2004
- 2004-07-23 KR KR1020067001782A patent/KR20060098425A/ko not_active Application Discontinuation
- 2004-07-23 NZ NZ544262A patent/NZ544262A/xx unknown
- 2004-07-23 US US10/898,690 patent/US7271170B2/en active Active
- 2004-07-23 JP JP2006521278A patent/JP2007500130A/ja active Pending
- 2004-07-23 PL PL04779031T patent/PL1648899T3/pl unknown
- 2004-07-23 DE DE602004004143T patent/DE602004004143T2/de active Active
- 2004-07-23 DK DK04779031T patent/DK1648899T3/da active
- 2004-07-23 AT AT04779031T patent/ATE350382T1/de not_active IP Right Cessation
- 2004-07-23 CA CA002537331A patent/CA2537331A1/en not_active Abandoned
- 2004-07-23 EP EP04779031A patent/EP1648899B1/en not_active Not-in-force
- 2004-07-23 PT PT04779031T patent/PT1648899E/pt unknown
- 2004-07-23 ES ES04779031T patent/ES2278345T3/es active Active
- 2004-07-23 BR BRPI0412908-3A patent/BRPI0412908A/pt not_active IP Right Cessation
- 2004-07-23 WO PCT/US2004/023794 patent/WO2005012306A2/en active IP Right Grant
- 2004-07-23 AU AU2004261591A patent/AU2004261591A1/en not_active Abandoned
- 2004-07-23 MX MXPA06000887A patent/MXPA06000887A/es active IP Right Grant
- 2004-07-26 TW TW093122247A patent/TW200524937A/zh unknown
- 2004-07-26 AR ARP040102649A patent/AR045117A1/es unknown
-
2006
- 2006-01-19 IL IL173265A patent/IL173265A0/en unknown
- 2006-10-17 HK HK06111339A patent/HK1089446A1/xx not_active IP Right Cessation
-
2007
- 2007-02-26 CY CY20071100262T patent/CY1107565T1/el unknown
- 2007-09-14 US US11/855,386 patent/US20080139580A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
DE602004004143T2 (de) | 2007-10-11 |
ES2278345T3 (es) | 2007-08-01 |
EP1648899B1 (en) | 2007-01-03 |
US20050038043A1 (en) | 2005-02-17 |
DE602004004143D1 (de) | 2007-02-15 |
KR20060098425A (ko) | 2006-09-18 |
JP2007500130A (ja) | 2007-01-11 |
NZ544262A (en) | 2009-06-26 |
PL1648899T3 (pl) | 2007-06-29 |
WO2005012306A2 (en) | 2005-02-10 |
CY1107565T1 (el) | 2013-03-13 |
WO2005012306A3 (en) | 2005-04-14 |
IL173265A0 (en) | 2006-06-11 |
EP1648899A2 (en) | 2006-04-26 |
PT1648899E (pt) | 2007-03-30 |
US20080139580A1 (en) | 2008-06-12 |
US7271170B2 (en) | 2007-09-18 |
TW200524937A (en) | 2005-08-01 |
HK1089446A1 (en) | 2006-12-01 |
ATE350382T1 (de) | 2007-01-15 |
CA2537331A1 (en) | 2005-02-10 |
AU2004261591A1 (en) | 2005-02-10 |
BRPI0412908A (pt) | 2006-09-26 |
MXPA06000887A (es) | 2006-04-19 |
DK1648899T3 (da) | 2007-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR047823A1 (es) | Derivados de 1,2,3,4-tetrahidroisoquinolina sustituida | |
AR025386A1 (es) | Moduladores de los receptores activados del proliferador de peroxisomas | |
AR053774A1 (es) | Derivados de sulfonilbencimidazol. composiciones farmaceuticas. | |
ECSP034865A (es) | Resolución óptica de (1-benzilo-4-metilopiperidina-3-il)-metilamina y su uso para la preparación de derivados de pirrolo 2,3-pirimidina como inhibidores de proteina quinasas | |
AR038536A1 (es) | N-aril-2-oxazolidinona-5- carboxamidas y sus derivados | |
AR062785A1 (es) | Compuestos de 4-metilpiridopirimidinona, composiciones farmaceuticas que los contienen y usos en estados patologicos asociados al crecimiento anormal celular,tal como cancer. | |
AR055150A1 (es) | Compuestos de isoindol - imido y composiciones que los comprenden y sus metodos de uso | |
AR071617A1 (es) | Bencenosulfonamidas de oxazol y tiazol, composiciones farmaceuticas que las contienen, proceso de preparacion y uso de las mismas como agentes anticancerigenos. | |
AR055878A1 (es) | Derivados de ciclopropanocarboxamida | |
AR055053A1 (es) | Compuestos indol sustituidos con actividad inhibidora de nos. composiciones farmaceuticas. | |
AR044045A1 (es) | Compuesto de piperidincarbonilpiperazina, composicion farmaceutica que lo comprende, su uso para la elaboracion de un medicamento y procedimiento para su preparacion | |
AR043436A1 (es) | Tetrahidroisoquinolinas sustituidas para uso como moduladores 5-ht6 | |
AR081932A1 (es) | Derivados de heteroaril imidazolona, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades neoplasicas y autoinmunes | |
RS50540B (sr) | Substituisani piridinil i pirimidinil derivati kao modulatori metabolizma i lečenje poremećaja proisteklih iz toga | |
AR034390A1 (es) | Derivados de 1-sulfonil-tetrahidro quinolinas sustituidas, composiciones farmaceuticas y el uso de las mismas para la elaboracion de medicamentos como inhibidores de la gama secretasa | |
AR053712A1 (es) | Heteroarilos sustituidos, antagonistas de cb1 (receptor 1 canabinoide) | |
HRP20050390A2 (en) | Substituted benzoxazinones and uses thereof | |
AR037676A1 (es) | Inhibidores del factor xa y de otras proteasas de serina implicadas en la cascada de la coagulacion; composicion farmaceutica que los comprende y procedimiento para preparar compuestos de formula (i) | |
AR058073A1 (es) | Derivados de imidazol 5-il-pirimidina, procesos de obtencion, composiciones farmaceuticas y usos | |
AR057408A1 (es) | Agonistas del receptor de niacina composiciones que contienen tales compuestos y procedimientos para tratamiento | |
AR086538A1 (es) | COMPUESTOS PARA REDUCIR LA PRODUCCION DE b-AMILOIDE | |
AR063988A1 (es) | Derivados heterociclicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
AR059184A1 (es) | Derivados de sulfonamidas, su preparacion y su aplicacion en tarapeutica | |
AR037907A1 (es) | Derivados de azaindolilalquilamina como ligandos de 5-hidroxitriptamina-6 | |
AR054287A1 (es) | Combinacion de herbicidas y antidotos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |